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Species of Searsia are used in traditional medicine to treat epilepsy. Previous studies on S. dentata and S. pyroides have shown that this is likely
mediated via the N-methyl-D-aspartic acid (NMDA) receptor. Ethanolic extracts of leaves of six Searsia species were tested in a binding assay for
afﬁnity to the NMDA-receptor. S. dentata, S. gerrardii, S. glauca, S. natalensis, S. pentheri and S. pyroides all contained compounds with afﬁnity
to the NMDA-receptor. The species with the best afﬁnity was S. pentheri. This might make it possible to use the Searsia species interchangeably,
so the more accessible Searsia species can be used in traditional medicine.
© 2011 SAAB. Published by Elsevier B.V. All rights reserved.
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Species from the genus Searsia (previously Rhus)
(Anacardiaceae) are used in South African traditional medi-
cine for treatment of mental disorders (Stafford et al., 2008).
Decoctions based on the bark from S. chirindensis are adminis-
tered for mental disturbances, roots from S. natalensis are
used for fits in children (Hutchings et al., 1996) and roots of
S. pyroides are used in infusions to treat delirium and epilepsy
(Gelfand et al., 1985).
A study by Risa et al. (2004), which investigated aqueous
and ethanolic extracts of leaves and roots of Sersia species,
showed that ethanolic extract of S. rehmanniana and S. tridentata
had significant affinity in the [3H]-flumazenil assay, indicating
compounds binding to the gamma-amino butyric-acid (GABA)
receptor. The water extracts were not active, and the leaves
were more active than the roots. The GABA system is the
main inhibitory system in the brain, and is involved in epilepsy.⁎ Corresponding author. Tel.: +45 35 336339; fax: +45 35 336041.
E-mail address: ankj@farma.ku.dk (A.K. Jäger).
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doi:10.1016/j.sajb.2011.10.002Further bioassay guided fractionation of the ethanolic extracts
of S. pyroides, S. dentata and S. pentheri demonstrated the
presence of three flavonoids, agathisflavone, amentoflavone and
apigenin, which showed affinity to the benzodiazepine binding
site on the GABAA receptor in the nM range (Svenningsen
et al., 2006). Studies showed that the ethanolic extracts of S.
pyroides and S. dentata inhibited the spontaneous epileptiform
discharge in a dose-dependent way in mouse cerebral cortical
slices (Pedersen et al., 2008). However, when the three flavo-
noids were tested in the mouse cortical wedge model, none of
them had effect (Pedersen et al., 2008), indicating that the activity
on the brain tissue was mediated via mechanisms other than
GABA, possibly via the N-methyl-D-aspartic acid (NMDA)
receptor. The NMDA-receptor is part of the excitatory glutamate
system in the brain, and is also involved in epilepsy. Binding
studies of ethanolic extracts of S. dentata and S. pyroides con-
firmed the presence of NMDA-receptor antagonists in the ex-
tracts (Pedersen et al., 2008). In vivo studies showed that
ethanolic extracts of S. pyroides protected 47% of 18-day-old
rats against NMDA-induced seizures (Pedersen et al., 2010). It
thus seems likely that the anti-epileptic effect sought in traditionalts reserved.
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extracts.
The aim of this study was to screen more species of the
Searsia genus for NMDA-receptor antagonists. The assay is a
binding assay, there compounds in the plant extract compete
with a radiolabeled ligand for the binding site on the NMDA-
receptor. If plant compounds have affinity to the binding site,
they will displace the radiolabeled ligand, and a lower level
of radioactivity will be measured in the brain homogenate.
Based on previous work (Pedersen et al., 2008, 2010), we
elected to investigate ethanolic leaf extracts.
Plant material was collected in the University of KwaZulu-
Natal Botanical Garden, Pietermaritzburg, and dried at 50 °C.
Vouchers are lodged at Bews Herbarium (NU), University
of KwaZulu-Natal, numbers are given in Table 1. Fifteen
grams of leaves was extracted three times with 200 ml ethanol
(Kemetyl A/S) in an ultrasound bath for 60 min. The combined
extracts were filtered before taken to dryness under vacuum.
The extracts were redissolved in DMSO (Sigma):Tris–HCl
buffer (Sigma) (1:9).Table 1
Binding of leaf extracts to the NMDA-receptor. The Ki-value for the S1 stereo-
isomer of 3-(2-carboxy-pyrrolidinyl)-2-methyl acetic acid was 22 μM.
Plant species Voucher no. Concentration
of extract in
ﬁnal assay
volume (μg/ml)
Speciﬁc
binding
(%)
Relative
standard
deviation
(%)
S. dentata (Thunb.)
F. A. Barkley
Stafford351NU 100 26 12
50 54 7
10 99 3
5 100 10
S. gerrardii (Engl.)
Moffett
Stafford354NU 100 54 6
50 71 9
10 86 14
5 95 8
S. glauca (Thunb.)
Moffett
Stafford356NU 100 25 6
50 44 6
10 81 5
5 41 60
S. natalensis
(Bernh. Ex Krauss)
F. A. Barkley
Stafford353NU 100 35 11
50 44 11
10 84 5
5 91 7
S. pentheri (A. Zahlbr.)
Moffett
Stafford352NU 100 10 9
50 25 9
10 55 13
5 71 7
S. pyroides (Burch.)
Moffett
Stafford355NU 100 23 24
50 52 7
10 96 11
5 101 1
Relative standard deviation=SD/mean×100.Cerebral cortices dissected from male Sprague–Dawley
rats (250 g) were homogenised in 10 volumes ice-cold 0.32 M
sucrose using an Ultra-Turrax homogeniser. The homogenate
was centrifuged at 1000 g for 10 min, and the resulting super-
natant was centrifuged at 18,000 g for 20 min. The pellet
was re-suspended and homogenised in 10 volumes of 5 mM
Tris–HCl buffer (pH 7.4) followed by centrifugation at
8000 g for 20 min. The resulting supernatant and upper buffy
coat layer of the pellet were combined and centrifuged at
48,000 g for 20 min. The pellet was re-suspended in 10 volumes
of 5 mM Tris–HCl buffer, homogenised and centrifuged at
48,000 g for 20 min. This wash step was repeated twice and the
final pellet was re-suspended in 10 volumes 5 mM Tris–HCl
buffer and stored at −18 °C. Before use in the assay, the homog-
enate was defrosted and washed as outlined above to remove any
glutamate naturally present in the tissue. The homogenate was
centrifuged at 48,000 g for 10 min. The pellet was re-suspended
in 40–50 volumes of 50 mM Tris–HCl+2.5 mM CaCl2
(Sigma) and centrifuged at 48,000 g for 10 min; this procedure
was repeated. The pellet was re-suspended to give 0.10–
0.11 mg original membrane tissue/200 μl.
The [3H]CGP 39653 binding assay was performed in a
96-well microplate. Twenty-five μl test solution, 25 μl [3H]
CGP 39653 (Perkin Elmer) (2 nM in final volume) and
200 μl membrane homogenate were added to a well. Non-
specific binding was determined using 1 mM (L)-glutamate
(Sigma), and total binding was determined using buffer
(50 mM Tris–HCl+2.5 mM CaCl2). The S1 stereoisomer of
3-(2-carboxy-pyrrolidinyl)-2-methyl acetic acid (Rasmussen
et al., 2011) was used as positive control. The plate was incu-
bated for 60 min on ice. Then a 96 well Packard Filtermate
cell harvester was used for filtration through a GF/B
filter (Perkin Elmer). To remove unbound radioactivity the
filter was washed three times with 250 μl ice-cold buffer.
The filter was dried at 50 °C. Thirty μl MicroScint 0 scintilla-
tion fluid (Perkin Elmer) was added to each filter-well and
the filter sealed before counting, using a Packard TopCount
scintillation counter. All experiments were done in triplicate.
The level of binding affinity to the NMDA-receptor was
calculated: specific binding (%)= ((DMP extract−DMP non-
specific binding) / (DMP total binding−DPM non-specific
binding))×100.
The results from the screening of Searsia leaf extracts
for affinity to the NMDA-receptor are shown in Table 1. The
results show that all six species contain compounds that gave
a response in the bioassay. The plant species with the best ac-
tivity was S. pentheri, as the values were markedly lower for
all four test concentrations. The activities obtained in this
study for S. dentata and S. pyroides were at a similar level
to those previously obtained for the two species (Pedersen et
al., 2008). The activity was dose-related for all six Searsia
species. In conclusion, S. dentata, S. gerrardii, S. glauca,
S. natalensis, S. pentheri and S. pyroides all contained com-
pounds with affinity to the NMDA-receptor. At this stage it
would appear that the compounds responsible for this activity
are common in the genus. It would be interesting to isolate
and identify the active compounds in Searsia and investigate
314 A.K. Jäger et al. / South African Journal of Botany 78 (2012) 312–314related genera with similar traditional use in treating epilepsy
such as Lannea.
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